Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harch Hyperbarics is a specialized medical practice and research organization focused on the application of Hyperbaric Oxygen Therapy (HBOT) for neurological conditions and wound healing. Founded by Dr. Paul Harch, a leading authority in hyperbaric medicine, the company utilizes pressurized oxygen protocols to treat chronic brain injuries such as TBI, PTSD, and stroke. The practice is renowned for its clinical research and the development of specific dosing protocols aimed at repairing damaged brain tissue through hyperbaric oxygenation. They provide direct clinical services while simultaneously conducting academic research to expand the recognized indications for HBOT. The organization serves as a global referral center for patients seeking advanced hyperbaric treatments for complex neurological disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harch Hyperbarics.